中华预防医学杂志
中華預防醫學雜誌
중화예방의학잡지
CHINESE JOURNAL OF
2013年
9期
848-854
,共7页
顾永恩%钱琴%余善法%张济%王丽%赵祖昌%宋艳双%陈田%杨敬林
顧永恩%錢琴%餘善法%張濟%王麗%趙祖昌%宋豔雙%陳田%楊敬林
고영은%전금%여선법%장제%왕려%조조창%송염쌍%진전%양경림
铬酸盐类%肝功能试验%微核试验%尿%成本效果分析
鉻痠鹽類%肝功能試驗%微覈試驗%尿%成本效果分析
락산염류%간공능시험%미핵시험%뇨%성본효과분석
Chromates%Liver function tests%Micronucleus tests%Urinary%Cost-effectiveness analysis
目的 对铬酸盐职业接触者现有健康监护方案监护指标进行循证研究,对该方案进行补充和完善.方法 于2011年12月以六价铬与肝损伤、微核、尿铬为主要检索内容,检索“考克兰图书馆(Cochran library)”、“PubMed”、“OVID Medline”、“Web of knowledge”与“中国生物医学文献数据库”等数据库.并对检索到的文献按照制定的纳入与排除标准筛选后,共计22篇;依据牛津证据分级标准,对其进行分级评价.结合作业场所现场调查及健康体检工作及卫生经济学手段,并以总成本与总存活生命年数计算成本效果比,对方案的有效性及可行性进行评价.结果 循证研究提示血清谷丙转氨酶(Alanine aminotransferase,ALT)不足以充分反映肝功损伤;尿铬与反映机体损伤的指标关联性较好;外周血淋巴细胞双核细胞微核率可反映铬酸盐接触的遗传损伤.铬酸盐制造业工人肺癌健康监护的卫生经济学评价结果:成本效果比(cost/effectiveness,C/E)为42 321.61元/年,而在普通人群中C/E >252 868.97元/年.结论 建议将检测血清谷丙转氨酶改为检测肝功能全项,尿铬由选检项目提升为必检项目,并增加外周血淋巴细胞双核细胞微核率作为选检项目.
目的 對鉻痠鹽職業接觸者現有健康鑑護方案鑑護指標進行循證研究,對該方案進行補充和完善.方法 于2011年12月以六價鉻與肝損傷、微覈、尿鉻為主要檢索內容,檢索“攷剋蘭圖書館(Cochran library)”、“PubMed”、“OVID Medline”、“Web of knowledge”與“中國生物醫學文獻數據庫”等數據庫.併對檢索到的文獻按照製定的納入與排除標準篩選後,共計22篇;依據牛津證據分級標準,對其進行分級評價.結閤作業場所現場調查及健康體檢工作及衛生經濟學手段,併以總成本與總存活生命年數計算成本效果比,對方案的有效性及可行性進行評價.結果 循證研究提示血清穀丙轉氨酶(Alanine aminotransferase,ALT)不足以充分反映肝功損傷;尿鉻與反映機體損傷的指標關聯性較好;外週血淋巴細胞雙覈細胞微覈率可反映鉻痠鹽接觸的遺傳損傷.鉻痠鹽製造業工人肺癌健康鑑護的衛生經濟學評價結果:成本效果比(cost/effectiveness,C/E)為42 321.61元/年,而在普通人群中C/E >252 868.97元/年.結論 建議將檢測血清穀丙轉氨酶改為檢測肝功能全項,尿鉻由選檢項目提升為必檢項目,併增加外週血淋巴細胞雙覈細胞微覈率作為選檢項目.
목적 대락산염직업접촉자현유건강감호방안감호지표진행순증연구,대해방안진행보충화완선.방법 우2011년12월이륙개락여간손상、미핵、뇨락위주요검색내용,검색“고극란도서관(Cochran library)”、“PubMed”、“OVID Medline”、“Web of knowledge”여“중국생물의학문헌수거고”등수거고.병대검색도적문헌안조제정적납입여배제표준사선후,공계22편;의거우진증거분급표준,대기진행분급평개.결합작업장소현장조사급건강체검공작급위생경제학수단,병이총성본여총존활생명년수계산성본효과비,대방안적유효성급가행성진행평개.결과 순증연구제시혈청곡병전안매(Alanine aminotransferase,ALT)불족이충분반영간공손상;뇨락여반영궤체손상적지표관련성교호;외주혈림파세포쌍핵세포미핵솔가반영락산염접촉적유전손상.락산염제조업공인폐암건강감호적위생경제학평개결과:성본효과비(cost/effectiveness,C/E)위42 321.61원/년,이재보통인군중C/E >252 868.97원/년.결론 건의장검측혈청곡병전안매개위검측간공능전항,뇨락유선검항목제승위필검항목,병증가외주혈림파세포쌍핵세포미핵솔작위선검항목.
Objective The health surveillance proposal for chromate exposed workers was provided and analyzed on the evidence-based study and then to be improved.Method Firstly,the related literatures were searched about liver damage,micronuclei,urinary chromium and hexavalent chromium exposure in Evidence Based Medicine Reviews such as Cochran library,OVID Medline,Web of knowledge in December 2011 ; and then,these literatures were reviewed in according to inclusion and exclusion criterias; 22 articles totally were retrieved,evaluated and classified in according to the grading standard by Oxford Centre for Evidence-based Medicine.Finally,field epidemiological investigation was further adopted to confirm the efficiency and feasibility of this proposal,combined with cost-effectiveness analysis:the ratio of total cost divided survival years was used to express the cost-effectiveness.Result Only the glutamic pyruvic transaminase test could not reflect liver damage caused by chromate exposure well; Unirary chromium correlated well with the index reflecting body damage caused by chromate exposure; Binucleated cells micronucleus index in peripheral blood lymphocyte could reflect the genetic damage caused by chromate exposure.As for health economic evaluation of chromate lung cancer,the value of cost/effectiveness was ¥42 321.61 per year that was far below the value of common people(¥ 252 868.97 per year).Conclusion It was suggested that serum glutamic pyruvic transaminase test should be replaced by liver function test,urinary chromium should be classified as a compulsory index and binucleated cells micronucleus index in peripheral blood lymphocyte should be supplied as a recommended index.